Citations

Clear

7552 citation(s) found for "Ho, Matthew".

Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma
Thompson, Carrie A. , Yost, Kathleen J. , Allmer, Cristine, Farooq, Umar , Inwards, David J. , Macon, William R. , Link, Brian K. , Rosenthal, Allison , Rosenthal, Allison C, Rosenthal, Allison , Link, Brian K , Farooq, Umar , Maurer, Matthew J. , Habermann, Thomas M. , Cerhan, James R.

Mayo Clinic

Hematological Oncology | June 4, 2018 | Volume: 36 | Issue: 5 | Pages: 749-756

10.1002/hon.2522 | PMID 29862550 Get It

AbstractOur aim was to evaluate whether quality of life (QOL) scores at diagnosis predict survival among patients with aggressive lymphoma. Newly diagnosed lymphoma patients were prospectively enrolled within 9 months of diagnosis in the University of Iowa/Mayo Clinic SPORE and systematically followed for event‐free and overall survival (OS). QOL was measured with the Functional Assessment of Cancer Treatment‐General (FACT‐G), which measures 4 domains: physical, social/family, emotional, and functional well‐being (WB); a single item Linear Analogue Self‐Assessment (LASA) measuring overall QOL; and a spiritual WB LASA. From 9/2002 to 12/2009, 701 patients with aggressive lymphoma who completed baseline QOL questionnaires were enrolled. At a median follow‐up of 71 months (range 6‐128), 316 patients (45%) had an event and 228 patients (33%) died. All baseline QOL measures but emotional WB were significantly associated with OS (all P < 0.04); of which all but LASA spiritual remained significant after adjusting for IPI and NHL subtype. The strongest associations were with total FACT‐G (adjusted HR = 0.86, 95% CI: 0.79‐0.94, P = 0.00062) and functional WB (adjusted HR = 0.88, 95% CI: 0.83‐0.93, P < .0001). QOL LASA was associated with OS (adjusted HR = 0.92, 95% CI: 0.87‐0.97, P = 0.0041). Patients with clinically deficient QOL (overall QOL ≤50) had a median OS of 92 months compared with 121 months for patients with QOL >50 (P = 0.0004). In this large sample of patients with aggressive lymphoma, we found that baseline QOL is independently predictive of OS. QOL should be assessed as a prognostic factor in patients with aggressive lymphoma.
Proposal for Modification of Cahan's Criteria Utilizing Molecular Genetic Analyses for Cases without Baseline Histopathology: A Unique Method Applicable to Primary Radiosurgery
Rusheen, Aaron E. , Smadbeck, James B. , Schimmenti, Lisa A. , Klee, Eric W. , Link, Michael J. , Vasmatzis, George , Carlson, Matthew L. , Schimmenti, Lisa A

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | May 31, 2018 | Volume: 80 | Issue: 01 | Pages: 010-017

10.1055/s-0038-1655759 | PMID 30733895 Get It

Background Cahan's criteria have been utilized since 1948 to establish causality between prior radiation treatment and the development of secondary malignancy. One major criterion specifies that histological and radiographic evidence collected before and after radiation treatment must confirm separate tumor types; however, pretreatment biopsy is rarely obtained prior to radiosurgery for vestibular schwannoma and many other skull base and cranial lesions. Therefore, in these cases Cahan's criteria cannot be validly applied. Objective This article proposes an update to Cahan's criteria using modern molecular genetic analysis for cases lacking baseline histopathology. Methods Mate-pair sequencing and whole exome sequencing of a cerebellopontine angle undifferentiated high-grade pleomorphic sarcoma (UHGPS) that developed after stereotactic radiosurgery of a presumed benign vestibular schwannoma. Results Mate-pair sequencing and whole exome sequencing of the sarcoma revealed complex chromosomal aberrations. Notably, the tumor contained a deletion in the NF2 gene at 22q12 and an in-frame deletion on exon 5 of the remaining copy of NF2. Biallelic events impacting NF2 are atypical for UHGPS but are characteristic for vestibular schwannoma. These findings help support the conclusion that the UHGPS arose from a benign vestibular schwannoma all along. Conclusions Next-generation sequencing can be successfully applied to a radiation-induced sarcoma when both the original and malignant tumors harbor separate signature genetic markers. As our understanding of the genetic profile of various tumors expand, we believe that next-generation sequencing and other genomic tools will play an increasingly important role in establishing causality between radiation and the development of secondary malignancy.
Direct Detection and Identification of Prosthetic Joint Infection Pathogens in Synovial Fluid by Metagenomic Shotgun Sequencing
Ivy, Morgan I. , Thoendel, Matthew , Jeraldo, Patricio , Greenwood‐Quaintance, Kerryl E. , Hanssen, Arlen D. , Yao, Janet , Tande, Aaron J. , Mandrekar, Jayawant N. , Patel, Robin , Thoendel, Matthew J, Jeraldo, Patricio R , Chia, Nicholas , Yao, Janet Z, Patel, Robin , Tande, Aaron , Abdel, Matthew P. , Chia, Nicholas , Thoendel, Matthew J

Mayo Clinic

Journal of Clinical Microbiology | May 31, 2018 | Volume: 56 | Issue: 9 | Pages: No page available

10.1128/jcm.00402-18 | PMID 29848568 Get It

Metagenomic shotgun sequencing has the potential to transform how serious infections are diagnosed by offering universal, culture-free pathogen detection. This may be especially advantageous for microbial diagnosis of prosthetic joint infection (PJI) by synovial fluid analysis since synovial fluid cultures are not universally positive and since synovial fluid is easily obtained preoperatively.
Remodeling of skeletal muscle mitochondrial proteome with high-fat diet involves greater changes to β-oxidation than electron transfer proteins in mice
Dasari, Surendra , Newsom, Sean A. , Ehrlicher, Sarah E., Stierwalt, Harrison D. , Robinson, Matthew M.

Mayo Clinic

American Journal of Physiology-Endocrinology and Metabolism | May 31, 2018 | Volume: 315 | Issue: 4 | Pages: E425-E434

10.1152/ajpendo.00051.2018 | PMID 29812987 Get It

Excess fat intake can increase lipid oxidation and expression of mitochondrial proteins, indicating remodeling of the mitochondrial proteome. Yet intermediates of lipid oxidation also accumulate, indicating a relative insufficiency to completely oxidize lipids. We investigated remodeling of the mitochondrial proteome to determine mechanisms of changes in lipid oxidation following high-fat feeding. C57BL/6J mice consumed a high-fat diet (HFD, 60% fat from lard) or a low-fat diet (LFD, 10% fat) for 12 wk. Mice were fasted for 4 h and then anesthetized by pentobarbital sodium overdose for tissue collection. A mitochondrial-enriched fraction was prepared from gastrocnemius muscles and underwent proteomic analysis by high-resolution mass spectrometry. Mitochondrial respiratory efficiency was measured as the ratio of ATP production to O2 consumption. Intramuscular acylcarnitines were measured by liquid chromatography-mass spectrometry. A total of 658 mitochondrial proteins were identified: 40 had higher abundance and 14 had lower abundance in mice consuming the HFD than in mice consuming the LFD. Individual proteins that changed with the HFD were primarily related to β-oxidation; there were fewer changes to the electron transfer system. Gene set enrichment analysis indicated that the HFD increased pathways of lipid metabolism and β-oxidation. Intramuscular concentrations of select acylcarnitines (C18:0) were greater in the HFD mice and reflected dietary lipid composition. Mitochondrial respiratory ATP production-to-O2 consumption ratio for lipids was not different between LFD and HFD mice. After the 60% fat diet, remodeling of the mitochondrial proteome revealed upregulation of proteins regulating lipid oxidation that was not evident for all mitochondrial pathways. The accumulation of lipid metabolites with obesity may occur without intrinsic dysfunction to mitochondrial lipid oxidation.
Revision endoscopic sinus surgery rates by chronic rhinosinusitis subtype
Miglani, Amar , Divekar, Rohit , Azar, Antoine , Rank, Matthew A. , Lal, Devyani , Divekar, Rohit D, Lal, Devyani

Mayo Clinic

International Forum of Allergy & Rhinology | May 31, 2018 | Volume: 8 | Issue: 9 | Pages: 1047-1051

10.1002/alr.22146 | PMID 29851243 Get It

BackgroundRevision surgery rates following endoscopic sinus surgery (ESS) range between 7% and 50% and are influenced by many factors. This study investigates ESS outcomes for chronic rhinosinusitis (CRS) subtypes.MethodsRetrospective review of adult CRS patients undergoing ESS with a single surgeon (2010‐2015) was conducted. Outcomes were analyzed by CRS subtypes.ResultsESS was performed in 424 CRS patients (CRS with nasal polyps [CRSwNP], n = 170; CRS without polyps [CRSsNP], n = 254). Most patients (309; 72.9%) could not be specifically subtyped; 115 (27.1%) were subtyped as follows: aspirin‐exacerbated respiratory disease (AERD), n = 47 (11.1%); allergic fungal sinusitis (AFS), n = 39 (9.2%); immunodeficiency, n = 21 (5.0%); granulomatosis with polyangiitis (GPA), n = 5 (1.2%); and eosinophilic granulomatosis with polyangiitis (EGPA), n = 3 (0.7%). All subgroups experienced clinically meaningful reduction in postoperative 22‐item Sino‐Nasal Outcome Test (SNOT‐22) scores. At median follow‐up of 28 months (interquartile range [IQR], 10–47 months), 19 patients (4%) underwent revision ESS (CRSwNP, n = 6; CRSsNP, n = 13). Revision ESS rates were 3.5% and 5.1% for CRSwNP and CRSsNP, respectively. Revision ESS rate for subtypes were: AERD 2%; AFS 2%; immunodeficiency 14%; GPA 40%; EGPA 0%; and “all other CRS” 4% at median follow‐up duration of 36, 28, 41, 37, 44, and 26 months, respectively.ConclusionAll CRS subtypes demonstrated clinically meaningful improvement in postoperative SNOT‐22 scores following ESS. Our overall revision ESS rate was 4% (3.5% in CRSwNP). AFS, AERD, and EGPA groups demonstrated low revision rates, while immunodeficiency and GPA patients required more revision surgery. A contemporary understanding of CRSwNP subtypes facilitated surgical and medical strategies in improving outcomes for AERD, AFS, and EGPA patients. CRSsNP subtypes with immunodeficiency and GPA merit further investigation to optimize outcomes.
The Association of Aspirin Use with Survival Following Radical Cystectomy
Lyon, Timothy D. , Frank, Igor, Shah, Paras , Tarrell, Robert F., Cheville, John C. , Karnes, R. Jeffrey , Thompson, R. Houston, Tollefson, Matthew K. , Boorjian, Stephen A. , Tarrell, Robert, Lyon, Timothy D

Mayo Clinic

Journal of Urology | May 29, 2018 | Volume: 200 | Issue: 5 | Pages: 1014-1021

10.1016/j.juro.2018.05.119 | PMID 29857079 Get It

Effect of physical activity (PA) before and after diagnosis on overall survival (OS) for patients (pts) with lymphoma.
Feldman, Andew L., Allmer, Cristine, Flowers, Christopher R. , Cohen, Jonathon B. , Thompson, Carrie A. , Ip, Andrew , Pophali, Priyanka A. , Larson, Melissa C. , Rosenthal, Allison , Maurer, Matthew J. , Link, Brian K. , Farooq, Umar , Slager, Susan L. , Habermann, Thomas M. , Cerhan, James R.

Mayo Clinic

Journal of Clinical Oncology | May 29, 2018 | Volume: 36 | Issue: 7_suppl | Pages: 95-95

10.1200/jco.2018.36.7_suppl.95 Get It

95 Background: While PA is known to improve quality of life in lymphoma pts, its impact on OS is not known. We studied the effect of PA on OS in lymphoma pts enrolled at diagnosis in the Iowa/Mayo Molecular Epidemiology Resource. Methods: Godin Leisure Score Index (LSI; Range 0-50) was calculated based on level of PA pre-diagnosis (baseline) and 3 years post diagnosis (FU3), with pts grouped by tertile into high, moderate, or low PA. At FU3, pts also reported perceived change in PA since diagnosis. OS was measured as time from assessment (baseline or FU3) until death from any cause. Associations between LSI tertiles and OS were assessed using Cox models adjusted for lymphoma subtype, age and sex. Results: PA level was available for 3060 pts at baseline and 1371 pts at FU3. 95% had an ECOG performance status < 2, 37% had an aggressive subtype, 29% had BMI ≥ 30, and 54% were age > 60. Indolent lymphoma pts with higher PA at baseline had no difference in OS. Higher PA at FU3 had improved OS (moderate vs low HR 0.63, CI 0.42-0.93; high vs low HR 0.53, CI 0.33-0.86). Pts with BMI < 30 who had higher PA at baseline showed no difference in OS. Higher PA at FU3 had improved OS for pts with BMI < 30 (moderate vs low HR 0.68 CI, 0.48-0.98; high vs low HR = 0.41, CI 0.26-0.64). For pts > 60 years, high vs low baseline PA showed improved OS (HR 0.77, CI 0.63-0.93). Higher PA at FU3 (moderate vs low HR 0.68 CI 0.48-0.96, high vs low HR 0.53 CI 0.34-0.83) was associated with OS. At FU3, compared to no change, perceived reduction of PA was associated with worse OS for indolent lymphoma (HR 2.13, CI 1.56-2.91), BMI < 30 (HR 1.95, CI 1.45-2.62), BMI > 30 (HR 2.00, CI 1.21-3.30), age ≤ 60 (HR 3.06, CI 1.72-5.46), and age > 60 (HR 1.98, CI 1.52-2.58). Perceived increase in PA was not associated with OS. Higher PA in pts with aggressive lymphoma, BMI ≥30, and age < 60 was not significantly associated with OS but trended similarly. All results were similar when analyzing by continuous LSI score. Conclusions: Higher levels of PA, especially at FU3, were associated with superior OS. The effect was more pronounced in pts with indolent lymphoma, BMI < 30, or age > 60. Perceived reduction in PA was associated with worse outcomes. PA should be incorporated into lymphoma survivorship plans.
Human Pegivirus infection and lymphoma risk and prognosis: a North American study
Famà, Angelo , Xiang, Jinhua , Link, Brian K. , Allmer, Cristine, Klinzman, Donna, Feldman, Andrew L. , Nowakowski, Grzegorz S. , Liebow, Mark , Maurer, Matthew J. , Ansell, Stephen M. , Novak, Anne J. , Asmann, Yan W. , Call, Timothy G. , Stapleton, Jack T. , Maurer, Matthew , Cerhan, James R , Feldman, Andrew L , Link, Brian K , Larson, Melissa C. , Slager, Susan L. , Habermann, Thomas M. , Cerhan, James R.

Mayo Clinic

British Journal of Haematology | May 29, 2018 | Volume: 182 | Issue: 5 | Pages: 644-653

10.1111/bjh.15416 | PMID 29808922 Get It

SummaryWe evaluated the association of Human Pegivirus (HPgV) viraemia with risk of developing lymphoma, overall and by major subtypes. Because this virus has also been associated with better prognosis in the setting of co‐infection with human immunodeficiency virus, we further assessed the association of HPgV with prognosis. We used risk factor data and banked plasma samples from 2094 lymphoma cases newly diagnosed between 2002 and 2009 and 1572 frequency‐matched controls. Plasma samples were tested for HPgV RNA by reverse transcription polymerase chain reaction (RT‐PCR), and those with RNA concentrations <5000 genome equivalents/ml were confirmed using nested RT‐PCR methods. To assess the role of HPgV in lymphoma prognosis, we used 2948 cases from a cohort study of newly diagnosed lymphoma patients (included all cases from the case‐control study). There was a positive association of HPgV viraemia with risk of lymphoma overall (Odds ratio = 2·14; 95% confidence interval [CI] 1·63–2·80; P < 0·0001), and for all major subtypes except Hodgkin lymphoma and chronic lymphocytic leukaemia/small lymphocytic lymphoma, and this was not confounded by other lymphoma risk factors. In contrast, there was no association of HPgV viraemia with event‐free survival (Hazard ratio [HR] = 1·00; 95% CI 0·85–1·18) or overall survival (HR = 0·97; 95% CI 0·79–1·20) for lymphoma overall, or any of the subtypes. These data support the hypothesis for a role of HPgV in the aetiology of multiple lymphoma subtypes.
Clinical and imaging progression over 10 years in a patient with primary progressive apraxia of speech and autopsy-confirmed corticobasal degeneration
Tetzloff, Katerina A. , Boland, Sarah, Utianski, Rene L. , Botha, Hugo , Senjem, Matthew L. , Josephs, Keith A. , Whitwell, Jennifer L. , Strand, Edythe A. , Boland, Sarah M, Utianski, Rene L , Senjem, Matthew L , Botha, Hugo , Duffy, Joseph R. , Machulda, Mary M. , Schwarz, Christopher G.

Mayo Clinic

Neurocase | May 25, 2018 | Volume: 24 | Issue: 2 | Pages: 111-120

10.1080/13554794.2018.1477963 | PMID 29799310 Get It

Evidence for telehealth group-based treatment: A systematic review
Gentry, Melanie T. , Clark, Matthew M. , Rummans, Teresa A. , Gentry, Melanie T , Lapid, Maria I.

Mayo Clinic

Journal of Telemedicine and Telecare | May 23, 2018 | Volume: 25 | Issue: 6 | Pages: 327-342

10.1177/1357633x18775855 | PMID 29788807 Get It

Background Interest in the use of telehealth interventions to increase access to healthcare services is growing. Group-based interventions have the potential to increase patient access to highly needed services. The aim of this study was to systematically review the available literature on group-based video teleconference services. Methods The English-language literature was searched using Ovid MEDLINE, PubMed, PsycINFO and CINAHL for terms related to telehealth, group therapy and support groups. Abstracts were reviewed for relevance based on inclusion criteria. Multiple study types were reviewed, including open-label, qualitative and randomised controlled trial study designs. Data were compiled regarding participants, study intervention and outcomes. Specific areas of interest were the feasibility of and satisfaction with telehealth technology, as well as the effect of video teleconference delivery on group dynamics, including therapeutic alliance. Results Forty published studies met the inclusion criteria and were included in the review. Six were randomised controlled trials. Among the studies, there was a broad range of study designs, participants, group interventions and outcome measures. Video teleconference groups were found to be feasible and resulted in similar treatment outcomes to in-person groups. However, few studies were designed to demonstrate noninferiority of video teleconference groups compared with in-person groups. Studies that examined group process factors showed small decreases in therapeutic alliance in the video teleconference participants. Conclusions Video teleconference groups are feasible and produce outcomes similar to in-person treatment, with high participant satisfaction despite technical challenges. Additional research is needed to identify optimal methods of video teleconference group delivery to maximise clinical benefit and treatment outcomes.